Bristol-Myers Squibb (NY:BMY)

Despite a Monday sell-off, stocks ended the week higher, and there's evidence that sector rotation is underway; next week's read of inflation may move markets.

MarketBeat Week in Review – 02/03 - 02/07

February 08, 2025

Via MarketBeat

Earnings Scheduled For February 6, 2025 ↗

February 06, 2025

Via Benzinga

Weak Guidance from Bristol-Myers Could Be Creating an Opportunity

February 07, 2025

Bristol-Myers stock fell after earnings, but analysts remain bullish which suggests that any dip in the stock may create a buying opportunity

Via MarketBeat

US Stocks Likely To Open On A Mixed Note: Amazon, Pinterest, Take-Two Among Stocks To Watch ↗

February 07, 2025

U.S. stocks could open mixed on Friday. Newell Brands, Flowers Foods, and Plains All American Pipeline to report earnings.

Via Benzinga

S&P 500 Gains For 3rd Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone ↗

February 07, 2025

Via Benzinga

Topics Stocks

Bristol Myers Squibb (BMY) Q4 2024 Earnings Call Transcript ↗

February 06, 2025

BMY earnings call for the period ending December 31, 2024.

Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday? ↗

Topics Earnings

February 06, 2025

It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged...

Via Benzinga

Topics Stocks

Dow Dips 150 Points; Bristol Myers Squibb Issues Weak Outlook ↗

February 06, 2025

Via Benzinga

Topics Stocks

Bristol Myers Squibb Tops Q4 Estimates ↗

February 06, 2025

Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.

Bristol-Myers Squibb Stock Slides On Weak 2025 Outlook, Retail Steps In To Buy The Dip ↗

February 06, 2025

The company announced plans to generate $2 billion in annual cost savings by the end of 2027.

Via Stocktwits

Wondering what's happening in today's S&P500 pre-market session? ↗

February 06, 2025

Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

Bristol Myers Squibb Warns Near-Term Impact Due To Generics On 2025 Sales Forecast, Outlines $2 Billion In Additional Cost Cuts ↗

February 06, 2025

Bristol Myers Squibb beat Q4 estimates with $12.34 billion revenue and $1.67 EPS. 2025 guidance lags expectations amid generic headwinds and cost-saving plans.

Via Benzinga

Bristol Myers Wallops Fourth-Quarter Earnings Views. But Shares Plummet 5%. ↗

February 06, 2025

Bristol Myers Squibb stock tumbled Thursday on a light outlook for 2025 following a strong fourth-quarter report.

Via Investor's Business Daily

Bristol-Myers Squibb (NYSE:BMY) Posts Better-Than-Expected Sales In Q4 But Full-Year Sales Guidance Misses Expectations

February 06, 2025

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced better-than-expected revenue in Q4 CY2024, with sales up 7.5% year on year to $12.34 billion. On the other hand, the company’s...

Via StockStory

Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2024

February 06, 2025

US Stocks Likely To Open Higher Ahead Of Amazon's Earnings: 'Buy The Dip' Mentality Remains Prevalent, Says Analyst ↗

February 06, 2025

U.S. stock futures rose on Thursday following Wednesday's advances as investors digest tariff pauses amid earnings reports.

Via Benzinga

Topics World Trade

Dow Rises Over 300 Points As Nvidia Surges: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone ↗

February 06, 2025

Via Benzinga

Topics Stocks

Bristol-Myers Squibb, Amazon And 3 Stocks To Watch Heading Into Thursday ↗

February 06, 2025

Via Benzinga

Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q4 Results Tomorrow

February 05, 2025

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be reporting results tomorrow before the bell. Here’s what you need to know.

Via StockStory

McDonald's To $290? Here Are 10 Top Analyst Forecasts For Tuesday ↗

February 04, 2025

Via Benzinga

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields ↗

February 04, 2025

Via Benzinga

Can Biotech Stocks Survive The Precarious Macro? ↗

February 03, 2025

We were having a nice rally in January 2025 until the reality of tariffs hit on Friday which killed the momentum developing off the mid-January lows.

Via Talk Markets

Topics Stocks / Equities World Trade

2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond ↗

February 03, 2025

Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts could pose risks for companies with significant drug exposure.

Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts ↗

January 31, 2025

Via Benzinga

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment Option for Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma

January 31, 2025

Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

January 31, 2025

3 Cheap Dividend Stocks That Pay More Than Double the S&P 500 Average ↗

January 29, 2025